![PRD_002367 PRD_002367](https://data.pdbj.org/pdbjplus/data/cc/svg/5R3.svg) | PRD_002367 | Name: | ~{N}-[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]-1-methyl-4-[3-[[1-methyl-4-[[1-methyl-4-[3-[[1-methyl-4-[(1-methylimidazol-2-yl)carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazol-2-yl]carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazole-2-carboxamide | Formula: | C41 H55 N17 O8 | Definition date: | 2022-08-03 | Last modified: | 2022-08-03 |
|
![PRD_002384 PRD_002384](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002384.svg) | PRD_002384 | Formula: | C58 H95 N15 O15 | Definition date: | 2022-08-03 | Last modified: | 2022-08-03 |
|
![PRD_002495 PRD_002495](https://data.pdbj.org/pdbjplus/data/cc/svg/K36.svg) | PRD_002495 | Name: | (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C21 H31 N3 O8 S | Definition date: | 2022-05-04 | Last modified: | 2022-05-04 |
|
![PRD_002455 PRD_002455](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002455.svg) | PRD_002455 | Name: | D-PMI-omega | Formula: | C82 H115 Cl N17 O20 | Definition date: | 2021-11-17 | Last modified: | 2021-11-17 |
|
![PRD_002454 PRD_002454](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002454.svg) | PRD_002454 | Name: | Substrate-like cysteine protease inhibitor | Formula: | C46 H70 Cl N10 O9 | Definition date: | 2021-09-01 | Last modified: | 2021-09-01 |
|
![PRD_002469 PRD_002469](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002469.svg) | PRD_002469 | Name: | Inhibitor 18 | Formula: | C30 H42 N4 O6 | Definition date: | 2021-08-25 | Last modified: | 2021-08-25 |
|
![PRD_002362 PRD_002362](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002362.svg) | PRD_002362 | Name: | GsIN-1 peptide | Formula: | C79 H106 N16 O21 S | Definition date: | 2021-04-21 | Last modified: | 2021-04-21 |
|
![PRD_002397 PRD_002397](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002397.svg) | PRD_002397 | Formula: | C41 H72 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
![PRD_002360 PRD_002360](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002360.svg) | PRD_002360 | Name: | myristoyl thiourea inhibitor, No. 23 | Formula: | C37 H67 N9 O5 S | Definition date: | 2021-03-24 | Last modified: | 2021-03-24 |
|
![PRD_002452 PRD_002452](https://data.pdbj.org/pdbjplus/data/cc/svg/TKP.svg) | PRD_002452 | Name: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C27 H40 Cl N3 O5 | Definition date: | 2020-10-14 | Last modified: | 2020-10-14 |
|
![PRD_002449 PRD_002449](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002449.svg) | PRD_002449 | Name: | (ACE)(1MH)D(B3L)F(1U8) | Formula: | C44 H54 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
![PRD_002450 PRD_002450](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002450.svg) | PRD_002450 | Name: | (ACE)(1MH)D(PF5)F(1U8) | Formula: | C46 H45 F5 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
![PRD_002352 PRD_002352](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002352.svg) | PRD_002352 | Formula: | C22 H31 N3 O7 | Definition date: | 2020-09-02 | Last modified: | 2020-09-02 |
|
![PRD_002267 PRD_002267](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002267.svg) | PRD_002267 | Name: | D-Arg4,Leu10-Teixobactin | Formula: | C59 H101 N14 O14 | Definition date: | 2020-08-19 | Last modified: | 2020-08-19 |
|
![PRD_002295 PRD_002295](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002295.svg) | PRD_002295 | Formula: | C89 H131 N23 O25 S3 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002127 PRD_002127](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002127.svg) | PRD_002127 | Name: | N-[4-(hydroxymethyl)benzoyl]-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C38 H54 N7 O11 P | Definition date: | 2014-12-03 | Last modified: | 2020-06-27 |
|
![PRD_002270 PRD_002270](https://data.pdbj.org/pdbjplus/data/cc/svg/9BA.svg) | PRD_002270 | Name: | N-{(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide | Formula: | C28 H44 N8 O5 | Definition date: | 2017-06-28 | Last modified: | 2020-06-21 |
|
![PRD_002393 PRD_002393](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002393.svg) | PRD_002393 | Name: | UAW247 | Formula: | C24 H27 N3 O5 | Definition date: | 2020-06-17 | Last modified: | 2020-06-17 |
|
![PRD_002347 PRD_002347](https://data.pdbj.org/pdbjplus/data/cc/svg/FHR.svg) | PRD_002347 | Name: | ~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | Formula: | C25 H32 N4 O4 | Definition date: | 2020-06-03 | Last modified: | 2020-06-03 |
|
![PRD_002349 PRD_002349](https://data.pdbj.org/pdbjplus/data/cc/svg/FJC.svg) | PRD_002349 | Name: | ~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | Formula: | C25 H25 F N4 O4 | Definition date: | 2020-06-03 | Last modified: | 2020-06-03 |
|
![PRD_002385 PRD_002385](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002385.svg) | PRD_002385 | Name: | Papain-like protease peptide inhibitor VIR250 | Formula: | C23 H32 N6 O6 S | Definition date: | 2020-05-20 | Last modified: | 2020-05-20 |
|
![PRD_002326 PRD_002326](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002326.svg) | PRD_002326 | Name: | Phosphinic inhibitor DG014 | Formula: | C62 H91 N9 O18 P | Definition date: | 2019-12-18 | Last modified: | 2019-12-18 |
|
![PRD_002334 PRD_002334](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002334.svg) | PRD_002334 | Name: | Linear tetrapeptide related to pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
![PRD_002335 PRD_002335](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002335.svg) | PRD_002335 | Name: | Linear precursor of pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Description: | Mle-Phe-Mle-Phe. Linear precursor of pseudoxylallemycin A. The peptide is linear, unlike Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic. | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
![PRD_002355 PRD_002355](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002355.svg) | PRD_002355 | Name: | Microcin C | Formula: | C38 H63 N17 O17 P S | Definition date: | 2019-07-10 | Last modified: | 2019-07-10 |
|